Announcements Trials
Browse Landscape

Phase

Phase 3 5Phase 2 4Phase NA 1Phase 1/2 1

Status

Not yet recruiting 2Active not recruiting 2Recruiting 1

Sponsor Class

OTHER 3NETWORK 2

Study Type

Interventional 5

Sponsor

Cancer Type

Other hematologic neoplasm 2Lymphoid 2Thoracic 1Head & Neck 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Nasopharyngeal Carcinoma 1Lymphoma, Large-Cell, Anaplastic 1Leukemia, Myeloid, Acute 1Carcinoma, Non-Small-Cell Lung 1

Interventions

pembrolizumab 130Carboplatin 127Cisplatin 118Paclitaxel 99Gemcitabine 87Specimen Handling 80Magnetic Resonance Spectroscopy 80Docetaxel 70Dexamethasone 62Cyclophosphamide 61Pemetrexed 59Capecitabine 56Bevacizumab 56durvalumab 52Oxaliplatin 52Fluorouracil 50Doxorubicin 49Radiotherapy 48Leucovorin 45Radiation 44Rituximab 43Lenalidomide 42Vincristine 39Etoposide 36Nivolumab 34atezolizumab 33Letrozole 32130-nm albumin-bound paclitaxel 32Irinotecan 31Prednisone 29

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 3 × Maintenance × 90 days × Clear all
NCT06277050 2026-05-15

Maintenance Therapy With Toripalimab and Capecitabine Versus Capecitabine Alone in High-risk Nasopharyngeal Carcinoma

Jiangxi Provincial Cancer Hospital

Phase 3 Recruiting
264 enrolled
Head & Neck

Nasopharyngeal Carcinoma

NCT07560358 2026-05-01

Adebrelimab Combined With Chemoradiotherapy in Patients With Large Bulky Stage III Unresectable Non-Small Cell Lung Cancer

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Phase 3 Not yet recruiting
204 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT07407140 2026-03-25

VAG-3+7-G

Institute of Hematology & Blood Diseases Hospital, China

Phase 3 Not yet recruiting
300 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT04881838 2026-03-19

CCCG-ALCL-2020 for Chinese Children and Adolescents With Newly Diagnosed High-risk ALCL

Children's Cancer Group, China

Phase 3 Active not recruiting
172 enrolled
Lymphoid

Lymphoma, Large-Cell, Anaplastic

NCT02845882 2026-03-18

LBL-2016 for Children or Adolescents in China

Children's Cancer Group, China

Phase 3 Active not recruiting
150 enrolled
LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡